SYMPOSIUM ON SPATIAL-TEMPORAL DATA SCIENCE FOR POPULATION HEALTH
Eric Boerwinkle, PhD
Dean of UTHealth Houston School of Public Health
Blake Hanson, PhD
Assistant Professor of UTHealth Houston School of Public Health Epidemiology, Human Genetics & Environmental Sciences
Qian Xiao, PhD
Associate Professor of UTHealth Houston School of Public Health Epidemiology, Human Genetics & Environmental Sciences
Jennifer Deegan, MPAff
Vice President of UTHealth Houston Office of the EVP and Chief Academic Officer of Health Policy and Systems Strategy
Kelly Nelson, PhD
Professor of MD Anderson, Department of Dermatology, Division of Internal Medicine
David Berrigan, PhD
Program Director of National Cancer Institute, Division of Cancer Control and Population Sciences, Behavioral Research Program
Wenjun Li, PhD
Professor of UMass Lowell Zuckerberg College of Health Sciences, Center for Health Statistics and Biostatistics Core, Health Statistics and Geography Lab
Date: Friday, March 1
Time: 9am - 4pm
Location: Cooley Center (7440 Cambridge St, Houston, TX 77054)
For More Information: porsha.vallo@uth.tmc.edu
Link to event: go.uth.edu/CSMAPS2024Symposium
Symposium: The IMPACT OF THE PANDEMIC ON DATA SCIENCE AND (BIO)STATISTICS
Dr. Mi Yan
Senior Data Scientist, Intuit Inc
Dr. Mikyoung Jun
Professor of Mathematics and ConocoPhillips Data Science, University of Houston
Dr. Xiaoying Yu
Associate Professor,
Department of Biostatistics & Data Science, The University of Texas Medical Branch
Dr. Cici Bauer
James W. Rockwell Professorship in Public Health (Preventive Medicine and Epidemiology) and Associate Professor Founding Director, Center for Spatial-Temporal Modeling for Applications in Population Science (CSMAPS)
Department of Biostatistics and Data Science, UTHealth School of Public Health
Dr. Yongsu Lee
Assistant Professor,
Department of Biostatistics and Data Science, UTHealth School of Public Health
Dr. Yiping (Bonnie) Dou
Assistant Professor,
Center for Spatial-Temporal Modeling for Applications in Population Science (CSMAPS) UTHealth School of Public Health
WHEN and WHERE: Friday, January 19, 2024 at Melcher Life Sciences Building, University of Houston
8:30am-1pm
Statistical Analysis with Electronic Health Records
Vahed Maroufy, PhD
Department of Biostatistics and Data Science, SPH, University of Texas HSC
Abstract: Electronic health records (EHR), although originally designed for billing and documentation purposes, are valuable resources to provide real-world evidences to evaluate treatment effects and disease risks. They are big data sources with full history record, including diagnosis, medication, procedure, demographic, Lab and clinical event table, which makes them strong choices for longitudinal analysis and prediction. They are, however, not precisely recorded, very noisy and heterogeneous, hence quite challenging to process, clean and prepare for statistical analyses. Common problems with preparing EHRs are: massive noise, intense missing, different variable types (cross-sectional, longitudinal, functional, …), etc. In this presentation, I give a review on the different directions and research projects under going in our department. We particularly use Cerner Health Factor database and Blue Cross Blue Shield (BCBSTX) insurance database. Cerner includes about 50M patients within 15 years period at around 700 hospitals around USA, and BCBSTX covers over 10M insured patients under 65 years of age in Texas. Specifically, I will discuss the issues and subtlety in data cleaning and processing and share a strategy we are developing for handling these issues. I will also briefly talk about three specific undergoing research projects based on these databases.
HACASA meetings are open to the public! Please pass on copies of this announcement to colleagues and friends and post on appropriate bulletin boards.
WHEN and WHERE: *Tuesday, September 11, 2018* at RAS Building, UT School of Public Health
5:30pm – 6:30pm, Social Hours, Room 102A
6:30pm – 7:30pm, Seminar, Room 102A
RAS Building is the primary building of UT School of Public Health, located at 1200 Pressler Street. For parking information and directions please refer to the UTSPH parking websites, the following have been found helpful:
https://sph.uth.edu/about-us/campus-locations-and-parking-information/
Thank you to UTHealth and the Department of Biostatistics and Data Science at UTSPH for their generous support of HACASA by allowing us the use of their facilities for our gatherings, and sponsoring FREE PARKING. See an officer for a voucher at the meeting.
To help us cover cost of our weekly snacks, we are asking for small donations ($5 or more). Also, please RSVP so we can bring enough snacks and drinks. Please RSVP to Kristofer Jennings at HoustonASA@gmail.com.
January 21, 2014
Heidi Spratt, PhD
Associate Professor UTMB Bioinformatics Program The University of Texas Medical Branch
Development of a Metabolic Biomarker Panel for the Early Diagnosis of Hepatocellular Carcinoma in Hepatitis C Infected Populations
Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer and also one of the deadliest. It has recently shown an upward trend in the number of diagnoses per year. One of the precursors to HCC infection is the Hepatitis C virus (HCV). According to the NIH, HCV is one of the main causes of chronic liver disease in the United States. About one-third of HCV patients will develop cirrhosis of the liver. Of those, about 1-2% annually will develop HCC. Ultimately, 80% of HCC cases are developed from liver cirrhosis. Hepatitis C causes an estimated ten to twelve thousand deaths each year in the U.S. alone; the virus varies greatly in both its course and disease outcome. Many patients infected with HCV are asymptomatic and have some degree of chronic hepatitis, often associated with some degree of fibrosis of the liver. The prognosis for patients with early-stage fibrosis is frequently good. At the other end of the spectrum are patients with severe HCV who experience all the classic symptoms of the disease, and who ultimately develop liver cirrhosis. The prognosis for such patients is slim and mortality is usually the result. Little is known about how HCV infection progresses to HCC in patients with advanced fibrosis, so the main goal of this project is to discover biomarkers for the detection of early stage liver cancer. Patients with HCV and HCC co-infection will be compared to HCV only infected patients to develop a biomarker panel for the detection of early stage liver cancer. For the development of such biomarkers, nuclear magnetic resonance metabolomics experiments will be conducted on urine samples from infected patients. Machine learning techniques such as multivariate adaptive regression splines will be used to create a biomarker panel that has the ability to predict HCC infection.